Introduction
Transforming growth factor-b (TGF-b) superfamily members (Activin, Bone Morphogenic Proteins, TGFbs, Decapentaplegic) are multifunctional cytokines, which aect cell proliferation, interactions with the extracellular matrix, and/or survival (Letterio and Roberts, 1997; MassagueÂ , 1998) . The TGF-bs signal via serine/threonine kinase transmembrane receptors which phosphorylate cytoplasmic mediators of the Smad family (Piek et al., 1999; MassagueÂ and Chen, 2000) . The ligand-speci®c Smad1, Smad2, Smad3 and Smad5, interact directly with, and are phosphorylated by, activated TGF-b receptor type I (Derynk et al., 1998) . Upon phosphorylation at their SSXS carboxyterminal motif, they form heteromeric complexes with Smad4, a common mediator for all Smad pathways (Derynk et al., 1998) . The resulting Smad heterocomplexes are then translocated into the nucleus where they activate target genes, binding DNA either directly or in association with other transcription factors (MassagueÂ and Wotton, 2000) . The inhibitory Smads, Smad6 and Smad7, prevent phosphorylation and/or nuclear translocation of receptor-associated Smads (Piek et al., 1999) . Interestingly, it has been shown that Smad7 expression may, in certain cell types, represent an autoinhibitory feedback loop downstream of the Smad signaling cascade (Nakao et al., 1997) .
The AP-1 family of transcription factors has also been implicated in various gene regulatory activities, either negative or positive, of TGF-b (Kerr et al., 1990; Kim et al., 1990; Mauviel et al., 1993 Mauviel et al., , 1996 Tang et al., 1998) . Modulation of AP-1/Jun expression by TGF-b is a cell-type speci®c phenomenon, as TGF-b activates c-jun expression only in epithelial cells, whereas it induces junB in mesenchymal cells (Mauviel et al., 1993 . These Jun family members exhibit dierent functional properties as transcription factors. Speci®cally, JunB is known to be a weak AP-1 transactivator as compared to c-Jun, and to even antagonize some of the transcriptional activities of c-Jun (Chiu et al., 1989; SchuÈ tte et al., 1989; Mauviel et al., 1993; Deng and Karin, 1993) .
Following the discovery of Smads as early transducing molecules downstream of the TGF-b receptors, it has been shown that activation of both c-jun and junB promoters by TGF-b involves Smad-dependent mechanisms (Jonk et al., 1998; Wong et al., 1999) . These results are consistent with the respective time courses of activation of Smad and Jun proteins by TGF-b. Speci®cally, using cultured human dermal ®broblasts, we have previously shown that Smad/DNA interactions occur rapidly and maximally within 10 min following TGF-b addition, persists at least 1 h, and are no longer detectable 3 h post-stimulation (Vindevoghel et al., 1998a) . On the other hand, induction of c-jun and junB expression occurs after Smad translocation, with maximal mRNA levels observed 1 ± 6 h after TGF-b stimulation (Mauviel et al., 1993 .
In this study, we have examined the role of TGF-binduced AP-1 expression on Smad-speci®c gene transcription downstream of TGF-b. We provide evidence for an inhibitory role of AP-1 members c-Jun and JunB on Smad-speci®c gene transactivation, a phenomenon which represents a novel suppressive feedback mechanism of Smad signaling.
Results
Overexpression of junB or c-jun prevents Smad-driven gene transactivation
As a ®rst approach to determine the role played by TGF-b-induced Jun expression on Smad-dependent gene activation, the eect of junB and c-jun overexpression was examined on the activation by either exogenous TGF-b or by Smad3 overexpression of the arti®cial Smad-speci®c construct (SBE) 4 -Lux. This reporter consists of four consensus Smad3/4 binding sequences cloned upstream of the SV40 promoter and driving the expression of the luciferase reporter gene (Zawel et al., 1998) . As shown in Figure 1 , neither junB nor c-jun alone had an eect on the basal activity of (SBE) 4 -Lux, whereas TGF-b induced its activity about threefold. The latter induction was totally prevented by overexpression of either c-jun or junB. A similar inhibitory activity of c-jun and junB overexpression was observed on Smad3-driven transactivation of (SBE) 4 -Lux (not shown). These results indicate that both c-Jun and Jun-B, members of the AP-1 family, directly antagonize Smad3-driven, TGF-b-induced, gene transactivation.
Antisense c-jun and junB expression enhance TGF-b-induced Smad-specific gene transactivation in human dermal fibroblasts and HaCaT keratinocytes
To examine the role played by endogenous Jun members on Smad-dependent gene activation, antisense c-jun and junB expression vectors (Mauviel et al., 1993 were utilized to block the expression of c-jun or junB, and their activation by TGF-b in either human dermal ®broblast or HaCaT keratinocyte cultures. First, the eect of the antisense vectors was examined on (SBE) 4 -Lux. As expected, TGF-b addition led to a signi®cant upregulation of (SBE) 4 -Lux in both ®bro-blasts and HaCaT keratinocyte cultures (Figure 2a, b, respectively) . In ®broblasts, antisense c-jun expression had little, if any, eect on TGF-b-induced transactivation, whereas antisense junB signi®cantly potentiated TGF-b eect (Figure 2a) . Inversely, antisense c-jun potentiated TGF-b eect in HaCaT keratinocytes whereas antisense junB did not (Figure 2b ).
From these experiments, it appears that Jun family members directly counteract Smad-speci®c transcription downstream of the TGF-b receptors in a cell-type speci®c manner: c-Jun plays a major role in epidermal keratinocytes only, whereas JunB is a potent inhibitor of Smad-speci®c gene expression downstream of TGFb in dermal ®broblasts. These data, indicating dierential eects of the antisense vectors used depending on the cell type are consistent with the cell-type speci®c induction of Jun components by TGF-b. Speci®cally, we have previously demonstrated that TGF-b selectively induces junB, and not c-jun, in dermal ®bro-blasts, whereas it potently enhances c-jun expression in epidermal keratinocytes (Mauviel et al., 1993 . It appears, therefore, that c-jun activation in keratinocytes, and junB activation in ®broblasts likely serve as a negative control mechanism against the rapid Smaddriven gene transactivation.
To test this hypothesis in the context of a natural promoter, we examined the eects of both antisense cjun and junB vectors on the upregulation of the human type VII collagen gene (COL7A1) promoter by TGF-b, previously identi®ed as a direct Smad target (Vindevoghel et al., 1998a,b) . Since COL7A1 is expressed in both ®broblasts and keratinocytes in the skin (Marinkowich et al., 1993) , it represents an ideal target to validate the results obtained using the arti®cial (SBE) 4 -Lux construct. As shown in Figure 2c , antisense junB signi®cantly elevated COL7A1 promoter activation by TGF-b in ®broblasts. Similarly, antisense c-jun en- Figure 1 Overexpression of c-jun and junB prevents TGF-binduced Smad-dependent activation of (SBE) 4 -Lux. Human dermal ®broblasts in late logarithmic growth phase were cotransfected with 3 mg of (SBE) 4 -Lux, with 6 mg of either pRSV/ junB or pRSV/c-jun expression vectors. Empty pRSVe was used to maintain equivalent amounts of transfected DNA in each plate. After glycerol shock, the cells were placed in medium supplemented with 1% FCS. Three hours later, TGF-b (10 ng/ml) was added where indicated and incubations were continued for 24 h, at which time reporter gene activity was determined. Luciferase activity (mean+s.d.) of three independent experiments performed in duplicate is shown in the form of bar graphs immortalized 3T3 cells (Schorpp-Kistner et al., 1999; Szabowski et al., 2000) was measured using (SBE) 4 -Lux as a Smad target construct. As shown in Figure 3 , transactivation by TGF-b of (SBE) 4 -Lux in junB 7/7 ®broblasts was twice that observed in wild-type ®broblasts. The dierence is consistent with the observations made in normal human ®broblasts in which blockade of junB expression resulted in similarly increased Smad-dependent transcriptional response (see Figure 2a ,c). Rescue of junB expression by transfection of a junB expression vector into junB 7/7 ®broblasts strongly inhibited TGF-b response of (SBE) 4 -Lux, to levels identical to those observed in the wild-type ®broblasts, con®rming that lack of junB expression is responsible for the increased Smad-dependent gene response in junB 7/7 ®broblasts.
c-Jun and JunB physically interact with Smad3 in solution and reduce Smad/DNA interactions To investigate the mechanisms by which Jun proteins antagonize Smad-mediated gene transactivation, we ®rst examined the possibility that Smad3 and Jun Wong et al., 1999; Liberati et al., 1999) . We next tested the ability of c-Jun and JunB to interact with Smad3/4, in the context of TGF-binduced Smad/DNA complexes. For this purpose, EMSA experiments were performed, using nuclear extracts from TGF-b-stimulated ®broblast cultures incubated with a radiolabeled Smad-speci®c 36CAGA probe (Dennler et al., 1998) . In vitro transcribed c-Jun or JunB were added to the binding reactions and their eects on TGF-b-induced Smad/DNA complex formation was determined. As shown in Figure 4b , TGF-b induced the formation of a unique Smad/DNA complex (lane 2 vs lane 1), consistent with our previous observations (Vindevoghel et al., 1998a,b) . Addition of in vitro synthesized c-Jun to the binding reaction strongly diminished Smad interactions with DNA, as compared to addition of an identical amount of mock TnT 1 reaction (lane 4 vs lane 2). A similar reduction in Smad/DNA complex formation was observed when JunB was added to the Smad/DNA binding reaction instead of c-Jun (not shown).
These experiments suggest that Smad3/Jun interactions in solution may sequester some of the available Smad3 and compete against Smad binding to its cognate cis-element, a phenomenon which likely inhibits Smad3-dependent transcription.
Discussion
It has been shown previously that induction of c-Jun and JunB components of the AP-1 family of transcription factors by TGF-b occurs downstream of the initial Smad cascade, as Smad-speci®c cis-elements are required for TGF-b-dependent activation of both c-jun and junB promoters (Jonk et al., 1998; Wong et al., 1999) . In this report, we have evidenced that secondary jun expression downstream of Smad signaling functions as a mechanism of suppression of Smad-speci®c gene transactivation. A schematic representation of the model is provided in Figure 5 . The model ®nds its bases in (i) the kinetics of Smad/DNA interactions and (ii) the kinetics of jun genes activation by TGF-b, as we determined previously (Mauviel et al., 1993; Vindevoghel et al., 1998a) . It is supported by the following new observations: ®rst, expression of an antisense junB vector in ®broblasts, and of an antisense c-jun vector in keratinocytes, respectively, leads to enhanced response of a Smad-speci®c reporter construct to TGF-b. These results were corroborated by experiments using junB 7/7 MEFs which exhibited signi®cantly higher responsiveness to TGF-b/Smad transactivation than parental control MEFs. Also, antisense junB expression in ®broblasts, and that of antisense c-jun in keratinocytes, potentiated the eect of TGF-b on the human COL7A1 promoter, previously identi®ed as a Smad target (Vindevoghel et al., 1998a,b) . Secondly, using immunoprecipitation/Western blotting techniques, we have demonstrated the existence of direct protein ± protein interactions between Smad3 and Jun family members. Thirdly, we have shown that Jun proteins have the ability to decrease Smad/DNA complex formation. The latter mechanism likely results in decreased transcriptional activity from Smad-speci®c cis-elements. These results are in agreement with the demonstration that interactions between Smad3 and Jun proteins occur between the MH1 domain of Smad3 and a 20 amino acids region close to the leucine zipper portion of c-Jun and JunB Liberati et al., 1999) . Because the MH1 domain of Smad3 is also its DNA binding domain, it is likely that o-DNA interactions with Jun proteins are not compatible with simultaneous DNA binding of Smad3, consistent with both our observations and with the deductions made from the crystal structure of the MH1 domain of Smad3 (Shi et al., 1998) .
In addition to preventing Smad3/DNA interactions, another possible mechanism for the inhibitory eect of Jun proteins on Smad-speci®c transcription could be that they sequester p300, a known transcriptional coactivator for both Smads and Jun proteins (Kamei et al., 1996; Janknecht et al., 1998; Feng et al., 1998; Shen et al., 1998) , whose availability within the nucleus is limited (Kamei et al., 1996; Hottiger et al., 1998) . Such sequestration of p300 by Jun family members would likely result in reduced Smad3-dependent transcription (Verrecchia et al., 2000) . Similarly, competition for p300 has been proposed to explain the antagonistic eects of E1A and RelA on c-Jun-and Smad3-mediated transcription (Lee et al., 1996; Maggirwar et al., 2000) .
In conclusion, this is the ®rst demonstration for a role of Jun/AP-1 family members as suppressors of Smad-dependent gene transactivation in the context of a regulatory feedback loop controlling initial transcriptional responses to TGF-b. This phenomenon is complementary to the previously described mechanism by which TGF-b may block Smad signaling via induction of inhibitory Smad7 (Nakao et al., 1997) . The latter prevents accessibility of the TGF-b receptors to substrate Smads, and prevents translocation of Smad3/Smad4 complexes into the nucleus (Nakao et al., 1997; Piek et al., 1999) , whereas the mechanism of suppression exerted by Jun proteins appear to occur directly at the level of Smad/DNA interactions, as described in this study.
Materials and methods

Cell cultures junB
7/7 mouse embryos ®broblasts (MEFs), obtained from the outgrowth of 9-day-old embryos in which targeted disruption of the junB gene has been performed (SchorppKistner et al., 1999) , and wild-type MEFs were immortalized according to the 3T3 protocol (Schreiber et al., 1995) . Human dermal ®broblast cultures, established by explanting tissue specimens obtained from neonatal foreskins, HaCaT keratinocytes (Boukamp et al., 1988) and MEFs were grown in Dulbecco's modi®ed Eagle's medium supplemented with 10% heat-inactivated fetal calf serum (FCS), 2 mM glutamine, and antibiotics (100 units/ml penicillin, 50 mg/ml streptomycin-G and 0.25 mg/ml Fungizone TM ). Human recombinant TGF-b1 was purchased from R&D Systems Inc. (Minneapolis, MN, USA). It is referred to as TGF-b throughout the text.
Plasmid constructs
(SBE) 4 -Lux (Zawel et al., 1998) was a kind gift from Dr Scott Kern, Johns Hopkins University, Baltimore, MD. For c-jun and junB expression, we used full-length human cDNAs cloned into pRSVe expression vector (Chiu et al., 1989) . The human type VII collagen gene (COL7A1) promoter construct 524COL7A1/CAT, a Smad3/4 responsive natural promoter, has been described previously (Vindevoghel et al., 1998a,b) . Tagged Smad3, c-Jun and JunB expression vectors, were obtained by subcloning the entire coding sequences into either pCDNA3-Flag, pCDNA3-Myc or pCDNA3-HA (Verrecchia et al., 2000) . Antisense c-jun and junB vectors have been described previously (Mauviel et al., 1993 . Integrity of all constructs was veri®ed by automated sequencing (ABI).
Transient cell transfections and reporter assays
Transient cell transfections were performed with the calcium phosphate/DNA co-precipitation procedure using a commer-cial assay kit (Promega Corp., Madison, WI, USA). Following appropriate incubation periods (see Figure  legends) , the cells were rinsed once with phosphate buered saline, harvested by scraping, and lysed in 200 ml of reporter lysis buer (Promega). pRSV-b-galactosidase was co-transfected in every experiment, and the b-galactosidase activities were used to monitor transfection eciency. Aliquots corresponding to identical b-galactosidase activity were used for each reporter assay. Luciferase activity was determined with a commercial assay kit according to the manufacturer's protocol (Promega). CAT activity was measured using [ 14 C]chloramphenicol as substrate, followed by thin layer chromatography. Quantitation was performed with a phosphorimager (Amersham-Pharmacia Biotech, Uppsala, Sweden).
In vitro protein synthesis T7 promoter-driven transcription and translation of c-Jun-HA and JunB-Flag proteins were performed in a single tube assay (TnT 1 , Promega Corp., Madison, WI, USA) according to the manufacturer's protocol.
Electrophoresis mobility shift assays
A 36CAGA Smad-speci®c oligonucleotide (Dennler et al., 1998) was used as a probe to determine Smad/DNA interactions. Nuclear extracts were isolated using a small scale preparation (Andrews and Faller, 1991) , aliquoted in small fractions to avoid repetitive freeze ± thawing, and stored at 7808C until use. Binding mixtures were separated electrophoretically on 4% acrylamide gels in 16Tris-Acetate-EDTA buer, pH 8.0.
Immunoprecipitations and Western blotting
COS-7 cells were transfected with an activated TbRI expression vector, together with tagged Smad3-Myc and cJun-HA expression vectors. 40 h later, cells were solubilized to perform immunoprecipitations and Western analyses using anti-Myc or anti-HA antibodies (Sigma), as described previously (Verrecchia et al., 2000) .
Abbreviations
CAT, chloramphenicol acetyl transferase; EMSA, electrophoretic mobility shift assay; FCS, fetal calf serum; SBE, Smad binding element; TGF-b, transforming growth factor-b. (Vindevoghel et al., 1998a) , leading to activation of direct target genes (X), including jun genes (mRNA expression pro®le deducted from Mauviel et al. (1993 Mauviel et al. ( , 1996 ). As a consequence of jun gene expression, the initial transactivation of Smad-dependent genes (X) is abbrogated by sequestration of Smad3 by Jun proteins which prevents its binding to speci®c DNA elements 
